KNSA
Kiniksa Pharmaceuticals, Ltd.
NASDAQ · BMHealthcareBiotechnology
$62.58-2.14%
Price as of Jul 20, 2026
KNSA capital
Kiniksa Pharmaceuticals, Ltd. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.30x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.08x
- Net debt / EBITDA
- -1.68x
Liquidity & coverage
- Current ratio
- 3.79x
- Quick ratio
- 3.33x
- Cash ratio
- 2.99x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $437.6M
Cash & dividend
- FCF / debt
- 18.20x
- Cash flow / debt
- 18.38x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.